Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Date:10/30/2008

ncludes amortization expense related to purchased intangible assets

as well as amortization of the inventory step-up related to the

acquisition of the former Merck Generics business.

(3) Integration and other non-recurring expenses include charges

principally related to the acquisition and integration of the former

Merck Generics business (e.g., non-recurring professional and

consulting fees, retention and other non-recurring expenses).

(4) The tax effect is calculated assuming an annual effective tax rate for

the resulting adjusted earnings. This tax effect adjustment results in

an effective tax rate on adjusted earnings that approximates 38%

before the impact of any tax synergies.

Below is a reconciliation of GAAP net earnings (loss) to adjusted EBITDA for the three and nine months ended Sept. 30, 2008:

Three months ended Nine months ended

($'s in millions) September 30, 2008 September 30, 2008

GAAP net earnings (loss) $206.8 $(176.0)

Add/(Deduct):

Minority interest (0.2) (2.3)

Income from equity method

investees (0.5) (3.2)

Income taxes 272.4 197.4

Interest expense 87.6 264.8

Depreciation & amortization 131.5 417.4

EBITDA 697.6 698.1

Add/(Deduct) Adjustments:

Non-cash stock-based

compensation expense 7.6 23.2

Bystolic revenues (455.0) (468.1)

Integration and other non-

recurring expenses 26.8 91.3

Goodwill impairme
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 Materials in Society ...   June 30 2015   Elsevier , ... and services and publishing home of Materials Today , ... the Materials in Society  Lecture Series . ... 8 th International Conference on Materials for Advanced Technologies ...
(Date:3/31/2015)... March 31, 2015   Mapi expands ... Medical Affairs and global Risk Management strength with ... previously announced acquisition . ... by a global team that includes physicians, pharmacists, ... of experience in navigating complex safety requirements throughout ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 ... and Professors from the top U.S and International Medical ... share their latest research on the application of stem ... diseases. The symposium is organized and funded by the ... independent nonprofit that has been convening intimate meetings of ...
(Date:3/30/2015)... San Francisco, CA (PRWEB) March 30, 2015 ... and tax incentives provided you the government, major companies ... state and local governments setting future mandates for renewable ... power as an option. , Solara Power is a ... to several incentive programs available that allow qualifying homeowners ...
Breaking Biology Technology:Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2
... Innocoll, Inc., a,privately held specialty pharmaceutical company, ... investment to raise $30 million through the ... placement with three,institutional investors led by Camulos ... and Morgan Stanley & Co, Incorporated. The ...
... is a new drug being,studied to prevent fractures in ... 3 clinical trial using denosumab were presented,Friday evening at ... from the Seattle Cancer Care Alliance., Denosumab is ... -- specialized cells that break down bone. Because it ...
... Per Acre Yield Advantage in Key ... Maturity Zone, ... showed that farmers who used DEKALB(R) corn seed stacked,with YieldGard VT Triple(TM) ... seed corn brands and,technologies in 2007., Data from nearly 1,700 on-farm ...
Cached Biology Technology:Innocoll Announces Closing of $30 Million Equity Financing Investment 2Innocoll Announces Closing of $30 Million Equity Financing Investment 3Innocoll Announces Closing of $30 Million Equity Financing Investment 4Innocoll Announces Closing of $30 Million Equity Financing Investment 5New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment 2Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits 2
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/24/2015)... Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of ... report to their offering. This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ...
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... New Rochelle, NY, October 3, 2008Novel platform technologies and ... of molecular diagnostics, reports Genetic Engineering and Biotechnology ... products can be significant as Kalorama Information predicts that ... reach $5.4 billion in four years, according to an ...
... Case Western Reserve University School of Medicine has been ... Children,s Study, the National Institutes of Health,s comprehensive study on ... At a briefing today, NIH officials named ... 36 new and existing study centers which would recruit study ...
... R.I. [Brown University] Brown University, with lead partner ... awarded a $12-million, five-year contract to expand its participation ... aimed at improving child health. The National Institute ... the 27 Institutes and Centers at the National Institutes ...
Cached Biology News:Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2NIH selects Case Western Reserve University to participate in National Children's Study 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 3Brown University and Women & Infants Hospital expand national children's study to Bristol County 4
... is causing shortages in your laboratory or fellow ... unwanted distractions, problems and delays. • ... and endeavour! Bring us your idea and let ... We work under ISO 9001 quality assurance in ...
Topoisomerase I...
...
... ADAM17 Activity Kit TNF-α Converting Enzyme Activity ... LIGHT. AVOID FREEZE/THAW CYCLES. The InnoZyme™ TACE ... assay designed to measure human TACE activity ... for screening enzyme inhibitors. An Anti-Human TACE-Coated ...
Biology Products: